ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AGL vs JNJ // FREE CASH FLOW YIELD

agilon health inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: AGL 0 — JNJ 9
▲ FREE CASH FLOW YIELD LEADER: JNJ
fcf-yield
2.97%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGL VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AGL JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 25.50% -60.50 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -8.25% 2.97% -11.22 JNJ /fcf-yield <GO>
Operating Margin -7.80% 34.70% -42.50 JNJ /operating-margins <GO>
Net Profit Margin -6.60% 28.50% -35.10 JNJ /net-margins <GO>
Revenue Growth (YoY) -2.10% 6.00% -8.10 JNJ /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.06 5.59 -3.53 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.0 62.1 -18.09 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.44B $662.49B -$661.05B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AGL REV JNJ REV AGL GROSS % JNJ GROSS % AGL FCF JNJ FCF
FY 2025 $5.93B $94.19B — 67.9% -$119.0M $19.70B
FY 2024 $6.06B $88.82B — 69.1% -$71.0M $19.84B
FY 2023 $4.32B $85.16B — — -$156.2M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGL // BETA —
JNJ // BETA 1.08